Koyfin Home > Directory > Health Care > Acceleron Pharma > Levered Free Cash Flow (FCF)

Acceleron Pharma Levered Free Cash Flow (FCF) Chart (XLRN)

Acceleron Pharma annual/quarterly Levered Free Cash Flow (FCF) from 2013 to 2020.
  • Acceleron Pharma Levered Free Cash Flow (FCF) for the quarter ending June 06, 2020 was $-38m a 41.86% decrease of -16m year over year
  • Acceleron Pharma Levered Free Cash Flow (FCF) for the last 12 months ending June 06, 2020 was $-100m a 36.31% decrease of -36m year over year
  • Acceleron Pharma Annual Levered Free Cash Flow (FCF) for 2019 was $-57m a 1.13% decrease of -1m from 2018
  • Acceleron Pharma Annual Levered Free Cash Flow (FCF) for 2018 was $-57m a 25.05% decrease of -14m from 2017
  • Acceleron Pharma Annual Levered Free Cash Flow (FCF) for 2017 was $-42m a 43.81% decrease of -19m from 2016
Other Cash Flow Metrics:
  • Acceleron Pharma Cash Flow from Operations for the quarter ending December 12, 2018 was $-29m a 19.28% decrease of -6m year over year
  • Acceleron Pharma Total Revenue for the quarter ending September 09, 2018 was $3m a -13.72% decrease of 0m year over year
View Chart On Koyfin

Quarterly XLRN Levered Free Cash Flow (FCF) Data

06/2020$-38m
03/2020$-29m
12/2019$-10m
09/2019$-22m
06/2019$-10m
03/2019$-15m
12/2018$-16m
09/2018$-11m
06/2018$-14m
03/2018$-15m

Annual XLRN Levered Free Cash Flow (FCF) Data

2019$-57m
2018$-57m
2017$-42m
2016$-24m
2015$-21m
2014$-28m
2013$-20m
2012$-1m